Brief: Acer Therapeutics Compliant With All Nasdaq Listing Criteria
29/12/2022 13:46
Dec 29 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS COMPLIANT WITH ALL NASDAQ LISTING
CRITERIA
Source text for Eikon: ID:nGNXhZJ5c
Further company coverage: ACER.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31